Table 2.
Risk factors of stroke subtypes among adult patients admitted to stroke unit of JUMC from March10–July 10, 2017
| Stroke risk factors | Total patients (n = 114) | Ischemic stroke (n = 59) | Hemorrhagic stroke (n = 55) | OR (P value) | |
|---|---|---|---|---|---|
| Hypertension | New diagnosis | 18 (20.5%) | 7 (16.3%) | 11 (24.4%) | 1.00 |
| Previous history | 70 (79.5%) | 36 (83.7%) | 34 (75.6%) | 0.345 | |
| Family history (n = 39) | Hypertension | 21 (53.8% | 12 (60.0%) | 9 (47.4%) | 0.584 |
| Sudden death | 15 (38.5% | 7 (35.0%) | 8 (42.1%) | 0.675 | |
| Diabetes mellitus | 10 (25.6%) | 6 (30%) | 4 (21.1%) | 0.585 | |
| Ischemic heart disease | 5 (12.8%) | 2 (10%) | 3 (15.8%) | 0.595 | |
| Stroke | 2 (5.1%) | 2 (10%) | 0 (0%) | 0.999 | |
| Alcohol intake | Former drinker | 22 (84.6% | 10 (100%) | 12 (75.0%) | 1.00 |
| Current alcohol use | 4 (15.4%) | 0 (0%) | 4 (25.0%) | 0.999 | |
| Smoking | Current smoker | 10 (50.0%) | 1 (16.7%) | 9 (64.3%) | 0.074 |
| Former smoker | 10 (50.0%) | 5 (83.3% | 5 (35.7%) | 1.00 | |
| Heart failure | 20 (17.2%) | 16 (26.7%) | 4 (7.1%) | 0.009 | |
| Atrial fibrillation | 19 (16.4%) | 15 (25.0%) | 4 (7.1%) | 0.014 | |
| Overweight/central obesity | 18 (15.5%) | 13 (21.7%) | 5 (8.9%) | 0.066 | |
| Hematological disorders (n = 17) | Polycythemia | 7 (41.2%) | 5 (45.5%) | 2 (33.3%) | 0.407 |
| Anemia | 6 (35.3%) | 4 (36.4%) | 2 (33.3%) | 0.459 | |
| Thrombocytopenia | 5 (29.4%) | 3 (27.3%) | 2 (33.3%) | 0.706 | |
| Thrombocytosis | 1 (5.9%) | 1 (9.1%) | 0 (0%) | – | |
| Diet (low fruit and vegetable) | 15 (12.9%) | 10 (16.7%) | 5 (8.9%) | 0.221 | |
| Coronary disease (CHD, IHD) | 14 (12.1%) | 11 (18.3%) | 3 (5.4%) | 0.043 | |
| Hypertensive heart disease (HHD) | 13 (11.2%) | 10 (16.7%) | 3 (5.4%) | 0.066 | |
| Physical inactivity/sedentary life | 13 (11.2%) | 9 (15.0%) | 4 (7.1%) | 0.189 | |
| Migraine or headache | 12 (10.3%) | 2 (3.3%) | 10 (17.9%) | 0.021 | |
| Psychosocial stress | 10 (8.6%) | 2 (3.3%) | 8 (14.3%) | 0.053 | |
| Traumatic brain /head injury | 9 (7.8%) | 2 (3.3%) | 7 (12.5%) | 0.085 | |
| Previous stroke | 9 (7.8%) | 8 (13.3%) | 1 (1.9%) | 0.048 | |
| Diabetes mellitus | Newly diagnosed | 4 (50% | 1 (25%) | 3 (75%) | 1.00 |
| Previous history | 4 (50%) | 3 (75%) | 1 (25%) | 0.178 | |
| Contraceptive drug use | 8 (6.9%) | 5 (8.3%) | 3 (5.4%) | 0.530 | |
| Hyperlipidemia (all newly diagnosed) | 6 (5.2%) | 5 (8.3%) | 1 (1.8%) | 0.148 | |
| Infective meningitis (TB / bacterial meningitis) | 5 (4.3%) | 1 (1.7%) | 4 (7.1%) | 0.182 | |
| Oral anticoagulant | 5 (4.3%) | 5 (8.3%) | 0 (0%) | 0.999 | |
| Nephrotic syndrome (Chronic kidney diseases) | 4 (3.4%) | 3 (5.0%) | 1 (1.8%) | 0.364 | |
| Epilepsy/seizure | 3 (2.6%) | 2 (3.3%) | 1 (1.8%) | 0.527 | |
| Other Malignancy/ history of other cancer | 3 (2.6%) | 1 (1.7%) | 2 (3.6%) | 0.528 | |
| Preeclampsia-eclampsia | 3 (2.6%) | 2 (3.3%) | 1 (1.8%) | 0.605 | |
| Other cardiovascular diseases such as DCM | 3 (2.6% | 3 (5.0%) | 0 (0%) | 0.999 | |
| VTE (hypercoagulable state) | 2 (1.7%) | 1 (1.7%) | 1 (1.8%) | 0.961 | |
| Hyperuricemia | 1 (0.9%) | 1 (1.7%) | 0 (0%) | – | |
| Thyrotoxicosis | 1 (0.9%) | 1 (1.7%) | 0 (0%) | – | |
| Chronic obstructive pulmonary disease (COPD) | 1 (0.9%) | 1 (1.7%) | 0 (0%) | – | |
| Valvular heart disease | 1 (0.9%) | 1 (1.7%) | 0 (0%) | – | |
| HIV | 1 (0.9%) | 1 (1.7% | 0 (0%) | – | |
| Other comorbidities | 3 (2.6%) | 3 (5%) | 0 (0%) | 0.999 | |
CHD Coronary Heart Disease, DCM Dilated Cardiomyopathy, HIV Human Immune Virus, IHD Ischemic Heart Disease, OR Odds ratio, TB Tuberculosis, VTE Venous thromboembolism